iinero.blogg.se

M.e.a.t. therapy
M.e.a.t. therapy






m.e.a.t. therapy

The question then is how much do you eliminate, and for how long? Because so many ‘healthy’ foods contain some molecules that are triggering a number of complaints. This is why implementing a strict elimination diet can help figure out the culprit. It is challenging to recognise a food intolerance as we eat so many foods (including all the unwanted ingredients such as preservatives and emulsifiers), coupled with the fact that the reaction can take up to 72 hours to appear. We know the impact of foods on our health, and figuring out which one doesn’t suit us and triggers our symptoms can be a nightmare. If food can be a medicine, it can also be a poison. Why a meat-based diet could be a good ideaĪ meat-based diet is the elimination diet by excellence. You probably heard of the bulletproof coffee, the drink where you add butter or heavy cream to your coffee, and have it for breakfast – they’d typically have it too. They all drink water, and most of them have coffee even if technical it’s a grain. There are some variations then, from ketocarnivores, who would add nuts and fruits/vegetables, to those following the lion diet, who only have beef and water. dairy (cheese, cream, milk, yoghurt, cottage cheese).Someone on a meat-based diet eats predominantly animal foods.

#M.e.a.t. therapy registration#

Trial registration NCT03173144.What is a carnivore diet, also called a meat-based diet? Based on the ITT population, differences between the dietary phenotypes in terms of the clinical response rate were analysed (while adjusting for the specific CID) in logistic regression models. The primary outcome was the proportion of patients with a clinical response to biologic therapy after 14-16 weeks of treatment. This was determined by the ratio of fibre to red/processed meat intake whereby HFLM constituted the upper tertile of the study sample and LFHM constituted the two lower tertiles of the study sample. The Intention-to-Treat (ITT) population was defined as those with completed baseline food frequency questionnaires enabling stratification into a high fibre/low red and processed meat exposed group (HFLM) and an unexposed group (low fibre/high red and processed meat intake = LFHM). Methods In this prospective multicentre cohort study we consecutively enrolled 233 adult patients with a diagnosis of CD, UC, RA, axSpA, PsA or PsO for whom biologic therapy was planned.

  • 22University of Southern Denmark, OPEN Explorative Network, Odense, Denmark.
  • 21University of Southern Denmark, Research Unit of Medical Gastroenterology, Odense, Denmark.
  • 20University of Southern Denmark, Clinical Institute, Odense, Denmark.
  • 19School of Health Sciences, University of Iceland, Faculty of Food Science and Nutrition, Reykjavik, Iceland.
  • 18University of Copenhagen, Department of Public Health, Section for General Practice, Copenhagen, Denmark.
  • 17The Parker Institute, Research Unit for Dietary Studies, Frederiksberg, Denmark.
  • 16Hospital of Southwest Jutland, Department of Gastroenterology, Esbjerg, Denmark.
  • 15Herlev Hospital, Department of Gastroenterology, Herlev, Denmark.
  • 14University Hospital of Southern Denmark, Aabenraa, Department of Research and Learning, Aabenraa, Denmark.
  • 13University Hospital of Southern Denmark, Department of Surgery, Aabenraa, Denmark.
  • 12University of Southern Denmark, Institute of Molecular Medicine, Odense, Denmark.
  • 11Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark.
  • 10Odense University Hospital, Department of Dermatology and Allergy Centre, Odense, Denmark.
  • 9Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark.
  • 8Silkeborg Regional Hospital, University Research Clinic for Innovative Patient Pathways, Silkeborg, Denmark.
  • m.e.a.t. therapy

    7Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark.6Institute of Molecular Medicine, University of Southern Denmark, Department of Cancer and Inflammation Research, Odense, Denmark.5Odense University Hospital, Department of Clinical Research, Research Unit of Rheumatology, Odense, Denmark.4University of Southern Denmark, Institute of Molecular Medicine, Odense, Denmark.3Institute for Regional Health Research, University of Southern Denmark, IRS-Center Soenderjylland, Aabenraa, Denmark.2The Parker Institute, Section for Biostatistics and Evidence-Based Research, Copenhagen, Denmark.1University Hospital of Southern Denmark, Aabenraa, The Molecular Diagnostics and Clinical Research Unit, Aabenraa, Denmark.








    M.e.a.t. therapy